Tollenaar RA - Search Results

1

The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.

Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS, Stoltenberg C, Romundstad P, Hveem K, Lillehaug JR, Vatten L, Devilee P, Dørum A, Lønning PE. Knappskog S, et al. Among authors: tollenaar ra. Cancer Cell. 2011 Feb 15;19(2):273-82. doi: 10.1016/j.ccr.2010.12.019. Cancer Cell. 2011. PMID: 21316605 Free article.

2

[From gene to disease; from BRCA1 or BRCA2 to breast cancer].

Devilee P, Tollenaar RA, Cornelisse CJ. Devilee P, et al. Among authors: tollenaar ra. Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2549-51. Ned Tijdschr Geneeskd. 2000. PMID: 11191790 Review. Dutch.

3

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.

de Bock GH, Tollenaar RA, Papelard H, Cornelisse CJ, Devilee P, van de Vijver MJ. de Bock GH, et al. Among authors: tollenaar ra. Br J Cancer. 2001 Nov 2;85(9):1347-50. doi: 10.1054/bjoc.2001.2103. Br J Cancer. 2001. PMID: 11720473 Free PMC article.

4

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment.

van Dijk S, Otten W, Zoeteweij MW, Timmermans DR, van Asperen CJ, Breuning MH, Tollenaar RA, Kievit J. van Dijk S, et al. Among authors: tollenaar ra. Br J Cancer. 2003 Jun 2;88(11):1675-81. doi: 10.1038/sj.bjc.6600988. Br J Cancer. 2003. PMID: 12771979 Free PMC article.

5

Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

de Bock GH, Tollenaar RA, Papelard H, Vliet Vlieland TP, Devilee P, Cornelisse CJ, Vandenbroucke JP. de Bock GH, et al. Among authors: tollenaar ra. J Natl Cancer Inst. 2003 Jul 2;95(13):1011-2; author reply 1012-3. doi: 10.1093/jnci/95.13.1011. J Natl Cancer Inst. 2003. PMID: 12837842 No abstract available.

6

Possible consequences of applying guidelines to healthy women with a family history of breast cancer.

van Asperen CJ, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, Brekelmans CT, Devilee P, Cornelisse CJ, Klijn JG, de Bock GH. van Asperen CJ, et al. Among authors: tollenaar ra. Eur J Hum Genet. 2003 Aug;11(8):633-6. doi: 10.1038/sj.ejhg.5201021. Eur J Hum Genet. 2003. PMID: 12891386

7

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.

de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Among authors: tollenaar ra. J Med Genet. 2004 Oct;41(10):731-5. doi: 10.1136/jmg.2004.019737. J Med Genet. 2004. PMID: 15466005 Free PMC article.

8

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.

van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA. van Sprundel TC, et al. Among authors: tollenaar ra. Br J Cancer. 2005 Aug 8;93(3):287-92. doi: 10.1038/sj.bjc.6602703. Br J Cancer. 2005. PMID: 16052221 Free PMC article.

9

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study.

Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ, Kenter GG. Gaarenstroom KN, et al. Among authors: tollenaar ra. Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:54-9. doi: 10.1111/j.1525-1438.2006.00480.x. Int J Gynecol Cancer. 2006. PMID: 16515568

10

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.

Kriege M, Brekelmans CT, Obdeijn IM, Boetes C, Zonderland HM, Muller SH, Kok T, Manoliu RA, Besnard AP, Tilanus-Linthorst MM, Seynaeve C, Bartels CC, Kaas R, Meijer S, Oosterwijk JC, Hoogerbrugge N, Tollenaar RA, Rutgers EJ, de Koning HJ, Klijn JG. Kriege M, et al. Among authors: tollenaar ra. Breast Cancer Res Treat. 2006 Nov;100(1):109-19. doi: 10.1007/s10549-006-9230-z. Epub 2006 Jun 22. Breast Cancer Res Treat. 2006. PMID: 16791481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page